Difficulty: Medium
Average Score: 86%
Practice
The drug, inhibiting viral reverse transcriptase:
Correct answer
A
Rationale
In this question, the correct answer is A) Zidovudine. Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) that works by inhibiting viral reverse transcriptase, an enzyme crucial for the replication of the human immunodeficiency virus (HIV). By blocking this enzyme, Zidovudine prevents the conversion of HIV RNA into DNA, thus hindering the virus from multiplying.
Option B) Vidarabine is an antiviral medication used to treat herpes simplex and varicella-zoster viruses. It does not inhibit viral reverse transcriptase, making it an incorrect choice for this question.
Option C) Rimantadine is an antiviral medication used to treat influenza A virus. It works by inhibiting the viral uncoating process and does not target reverse transcriptase, so it is not the correct answer.
Option D) Gancyclovir is an antiviral medication used to treat cytomegalovirus (CMV) infections. It works by inhibiting viral DNA polymerase, not reverse transcriptase, making it an incorrect choice in this context.
Educationally, understanding how different antiviral drugs target specific viral enzymes or processes is crucial in the field of pharmacology. Knowing the mechanisms of action of these drugs helps healthcare professionals make informed decisions when prescribing medications and managing patients with viral infections. This knowledge is vital for ensuring the effectiveness of treatments and minimizing the development of drug resistance.
Option B) Vidarabine is an antiviral medication used to treat herpes simplex and varicella-zoster viruses. It does not inhibit viral reverse transcriptase, making it an incorrect choice for this question.
Option C) Rimantadine is an antiviral medication used to treat influenza A virus. It works by inhibiting the viral uncoating process and does not target reverse transcriptase, so it is not the correct answer.
Option D) Gancyclovir is an antiviral medication used to treat cytomegalovirus (CMV) infections. It works by inhibiting viral DNA polymerase, not reverse transcriptase, making it an incorrect choice in this context.
Educationally, understanding how different antiviral drugs target specific viral enzymes or processes is crucial in the field of pharmacology. Knowing the mechanisms of action of these drugs helps healthcare professionals make informed decisions when prescribing medications and managing patients with viral infections. This knowledge is vital for ensuring the effectiveness of treatments and minimizing the development of drug resistance.